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Background & Objectives: More than half of all clinical isolates produce the blue-green 
pigment pyocyanin. These pathogens are widespread in nature, inhabiting soil, water, plants, 
and animals (including humans). Pseudomonas aeruginosa has become an important cause of 
infection, especially in patients with compromised host defense mechanisms. Biofilms, 
communities of cells adhering to a substratum, likely represent the prevalent form of 
microorganisms in nature. Resistance to antimicrobials is a general feature of all biofilms that 
are the major cause of recalcitrant infections. Biofilms might be responsible for 65% of all 
bacterial infections. One obvious difference between planktonic cells and biofilm is the 
presence of a polysaccharide matrix enveloping the community that retards diffusion of 
antimicrobials into the biofilm.  
Methods: Strains isolated from various clinical specimens November 2010 from Amam 
Ahvaz Hospital, Iran. The bacteria were grown in Luria-Bertani (LB) broth or LB agar 
containing the appropriate antibiotics. All samples were subjected to disk diffusion 
susceptibility testing Minimum Inhibitory Concentrations of piperacillin, 
cefoperazone,ceftazidime, cefotaxime, cefepime, imipenem, meropenem, gentamicin, 
amikacin, tobramycin,and ciprofloxacin for 100 Pseudomonas aeruginosa strains isolated. 
Results: Pseudomonas aeruginosa strains were the most sensitive to ceftazidime 
(78.9%),imipenem (73.6%), meropenem (70.9%) and the most resistant to gentamicin 
(54.1%) and ciprofloxacin (52.5%). 
Conclusion: Multi-drug resistant Pseudomonas aeruginosa nosocomal infections are 
increasingly recognized worldwide. aminoglycosides (gentamicin, amikacin, tobramycin), 
quinolones (ciprofloxacin, levofloxacin, but not moxifloxacin),cephalosporins (ceftazidime, 
cefepime, cefoperazone, cefpirome, but not cefuroxime, ceftriaxone, cefotaxime), 
antipseudomonal penicillins: ureidopenicillins and carboxypenicillins (piperacillin, ticarcillin: 
P. aeruginosa is intrinsically resistant to all other penicillins),carbapenems (meropenem, 
imipenem, doripenem, but not ertapenem), polymyxins (polymyxin B and colistin), 
monobactams (aztreonam). The risk of emergence of antibiotic resistance may vary with 
different antibiotic treatments. 
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